96898 ⎘
Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
Genetically encoded system for constructing and detecting biologically active agents
#602RECOMBINANT VACCINES AND METHODS OF USE THEREOF
#603Neoantigen vaccines for triple negative breast cancer
#604Transdermal Optogenetic Peripheral Nerve Stimulation
#605RIGID HELICAL JUNCTIONS FOR MODULAR REPEAT PROTEIN SCULPTING AND METHODS OF USE
#606COMPOSITIONS FOR PREVENTING OR TREATING VIRAL AND OTHER MICROBIAL INFECTIONS
#607Phage-displayed accessible recombinant targeted antibodies and methods of making same
#608OPTIMIZED EXPRESSION CASSETTES FOR GENE THERAPY
#609BINDING PROTEINS USEFUL AGAINST ACE2-TARGETED VIRUSES
#610ANTI-PACAP ANTIBODIES AND USES THEREOF
#611D-DOMAIN CONTAINING POLYPEPTIDES AND USES THEREOF
#612COMPOSITIONS AND METHODS FOR THE TREATMENT OF CONGENITAL ICHTHYOSES
#613COMPOSITIONS AND METHODS FOR IMPROVING VIRAL VECTOR EFFICIENCY
#614SPLIT INTEINS AND THEIR USES
#615HIGH-PURITY PURIFICATION TECHNIQUE FOR Gc PROTEIN
#616De novo designed protein homodimers containing tunable symmetric pockets
#617NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#618ASSAY AND KIT FOR LIVE ANTIGEN DETECTION AND MONITORING OF NEUROCYSTICERCOSIS
#619Compositions and methods for treating non-age-associated hearing impairment in a human subject
#620METHOD OF ENHANCING IMMUNOTHERAPY USING ER STRESS PATHWAY INHIBITORS
#621Combination of Retromer Pharmacological Chaperones and Exogenous Retromer for the Treatment of Alzheimer's Disease and Other Neurodegenerative Diseases and Disorders
#622QUANTITATIVE CONTROL OF ACTIVITY OF ENGINEERED CELLS EXPRESSING SPYCATCHER AND SPYTAG UNIVERSAL IMMUNE RECEPTORS
#623Fused cyclooctyne compounds and their use in metal-free click reactions
#624NON-HUMAN ANIMALS COMPRISING A HUMANIZED TTR LOCUS COMPRISING A V30M MUTATION AND METHODS OF USE
#625LARGE GENE VECTORS AND DELIVERY AND USES THEREOF
#626Compositions and methods for treating non-age-associated hearing impairment in a human subject
#627Pneumococcal fusion protein vaccines
#628NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#629NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#630IFIT Polypeptides and Uses for Treating Tuberculosis Infection
#631SEMG2 ANTIBODY AND USE THEREOF
#632Non-human animals comprising a humanized TTR locus and methods of use
#633NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS
#634Methods to spatially profile protease activity in tissue and sections
#635ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS
#636Systemic administration of peptides for the treatment of spinal cord injury and/or for remyelination
#637PROSTATE TARGETING ADENO-ASSOCIATED VIRUS SEROTYPE VECTORS
#638C-PEPTIDES AND PROINSULIN POLYPEPTIDES COMPRISING THE SAME
#639STRUCTURE-BASED PEPTIDE INHIBITORS OF ALPHA-SYNUCLEIN AGGREGATION
#640ANIMAL MODELS OF LIPID METABOLISM AND METHODS OF TREATING HYPERLIPIDEMIA OR HYPERLIPIDEMIA-RELATED DISEASES
#641CANCER GENE THERAPY DRUG
#642SERUM AMYLOID P DERIVATIVES AND THEIR PREPARATION AND USE
#643PLAKOPHILLIN-2 GENE THERAPY METHODS AND COMPOSITIONS
#644PLASMIN-RESISTANT PEPTIDES FOR TREATING STROKE AND RELATED CONDITIONS
#645MARKER FOR PANCREATIC CANCER AND INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS
#646MULTIMERIZATION DELIVERY SYSTEM FOR INTRACELLULAR DELIVERY OF MOLECULE
#647Methods of reducing FUS/TLS- or TDP-43-mediated neuronal cytotoxicity in amyotrophic lateral sclerosis (ALS) by UPF2
#648RNA containing modified nucleosides and methods of use thereof
#649PLAKOPHILLIN-2 GENE THERAPY METHODS AND COMPOSITIONS
#650POLYPEPTIDE FRAGMENT B (MP-B) AND USE THEREOF
#651Nucleobase Editors
#652Methods and compositions for screening and treating developmental disorders
#653COMPOSITIONS AND METHODS FOR PRODUCING FOOD PRODUCTS WITH RECOMBINANT ANIMAL PROTEIN
#654IN VITRO AND IN VIVO GENE DELIVERY TO IMMUNE EFFECTOR CELLS USING NANOPARTICLES FUNCTIONALIZED WITH DESIGNED ANKYRIN REPEAT PROTEINS (DARPINS)
#655NME VARIANT SPECIES EXPRESSION AND SUPPRESSION
#656Optimized protein fusions and linkers
#657Compositions and methods for targeting nuclear import shuttles and treating inflammatory disorders
#658Compositions and methods for identifying RNA binding polypeptide targets
#659MULTI-FUNCTIONAL NANOPARTICLE TARGETED TO BREAST CANCER, PREPARATION METHOD AND USE THEREOF
#660Rescue of central and peripheral neurological phenotype of friedreich's ataxia by intravenous delivery
#661Therapeutic editing
#662Nucleic acids, methods and kits for the diagnosis of DYT6 primary torsion dystonia
#663PLAKOPHILLIN-2 GENE THERAPY METHODS AND COMPOSITIONS
#664METHODS AND SYSTEMS FOR IN-VITRO MILK PRODUCTION
#665SECRETABLE PROTEIN INDUCED IMMUNE TOLERIZATION AND TREATMENT OF AUTOIMMUNE, ALLERGIC AND OTHER DISEASES AND DISORDERS
#666Genetically modified probiotics for oral delivery of renin-angiotensin related therapeutic proteins and peptides
#667TEIPP PEPTIDE VARIANT AND USES THEREOF
#668TISSUE ADHESION COMPOSITION WITH BIO-TISSUE ADHESIVENESS AND BONDING FORCE AND PREPARATION METHOD THEREFOR
#669GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78
#670CRISPR-CAS EFFECTOR POLYPEPTIDES AND METHODS OF USE THEREOF
#671CELL-PENETRATING PEPTIDE DIMERS, METHOD FOR PREPARING THE SAME, AND CARGO DELIVERY SYSTEM USING THE SAME
#672Rapid assay for detection of SARS-CoV-2 antibodies
#673Stabilization of Retromer for the Treatment of Alzheimer's Disease and Other Neurodegenerative Disorders
#674CROSS-LINKED PRODUCT OF AMYLOID-B PROTEIN (AB) AS POTENTIAL SUBSTITUTE FOR AMYLOSPHEROIDS (ASPD) AND ANALYSIS OF ASPD
#675MODULATION OF PROTEIN DEGRADATION
#676Heterodimeric proteins for modulating gamma delta T cells
#677Signal-sensor polynucleotides for the alteration of cellular phenotypes
#678REGULATION OF RAN TRANSLATION BY PKR AND EIF2A-P PATHWAYS
#679SMALL MOBILE STEM CELLS (SMS) AND USES THEREOF
#680Inducible caspases and methods for use
#681COMPOUND AND METHOD FOR TREATMENT OF ALZHEIMER'S DISEASE
#682Antitumor peptide and use thereof
#683COMPOSITIONS AND METHODS OF USING ENGINEERED FUSION PROTEINS THAT BIND G4C2 HUMAN REPEATS
#684COMPOSITION FOR PREVENTING OR TREATING BONE DISEASES COMPRISING CCR2
#685NEURONAL VIABILITY FACTOR AND USE THEREOF
#686PROTEINS CONTAINING MULTIPLE, DIFFERENT UNNATURAL AMINO ACIDS AND METHODS OF MAKING AND USING SUCH PROTEINS
#687MINIMAL ARRESTIN DOMAIN CONTAINING PROTEIN 1(ARRDC1) CONSTRUCTS
#688PEPTIDES AND COMPOSITIONS FOR TREATMENT OF JOINT DAMAGE
#689CHROMOGRANIN A-DERIVED PEPTIDES AND USES THEREOF
#690BIOMARKERS AND TREATMENTS OF ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT
#691MESENCHYMAL STEM CELL EXPRESSING TRAIL AND CD, AND USE THEREOF
#692POROUS PROTEIN PARTICLES AS CARRIERS FOR ACTIVES
#693IMPORTATION OF MITOCHONDRIAL PROTEIN BY AN ENHANCED ALLOTOPIC APPROACH
#694NON-NATURALLY OCCURRING CAPSIDS FOR DELIVERY OF NUCLEIC ACIDS AND/OR PROTEINS
#695Proteins with cardioprotective activity
#696Therapeutic Agent for Psoriasis
#697CD86 VARIANT IMMUNOMODULATORY PROTEINS AND USES THEREOF
#698NOVEL RECEPTORS HAVING A HETEROLOGOUS STOP TRANSFER SEQUENCE FOR LIGAND-DEPENDENT TRANSCRIPTIONAL REGULATION
#699Erythropoietin-derived peptides and methods of protecting cells from oxidative damage induced by reactive oxygen species
#700PHARMACEUTICAL COMPOSITION, COMPRISING RECOMBINANT STABILIZED GALECTIN 9 PROTEIN, FOR PREVENTION OR TREATMENT OF RHEUMATOID ARTHRITIS AND BONE DISEASE
#701MODULATORS OF MYC, METHODS OF USING THE SAME, AND METHODS OF IDENTIFYING AGENTS THAT MODULATE MYC
#702Chimeric protein in the treatment of amyloidosis
#703POLYPEPTIDE-FC CONJUGATE WITH ATTENUATED IMMUNE RESPONSE
#704NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#705RNA VIRUS VECTORS CARRYING DAI AND RIPK3
#706GRP78-binding antibodies and uses thereof in detecting or neutralizing GRP78
#707ENGINEERING BROADLY REACTIVE HUMAN NOTCH LIGANDS AS NOVEL TOOLS FOR BIOMEDICAL APPLICATIONS
#708EXPRESSION OF NEUROPEPTIDES
#709VCX/Y PEPTIDES AND USE THEREOF
#710COMPOSITIONS AND METHODS FOR DIAGNOSIS OF PERIPHERAL ARTERIAL DISEASE
#711BRAIN-CHIP MODELING NEURODEGENERATION AND NEUROINFLAMMATION IN PARKINSON'S DISEASE
#712MODIFIED FC REGION
#713METHODS FOR TREATMENT OF CANCER COMPRISING TIGIT-BINDING AGENTS
#714N-terminal capping modules of ankyrin repeat domains
#715RNA-BINDING PROTEIN
#716NOVEL MICROPEPTIDE HMMW AND APPLICATION THEREOF
#717HUMAN-DERIVED ANTI-HUNTINGTIN (HTT) ANTIBODIES AND USES THEREOF
#718ANTI-HOG TCN1 MONOCLONAL ANTIBODIES AND METHODS OF PRODUCTION AND USE THEREOF
#719Hybrid ActRIIB ligand trap proteins for treating muscle wasting diseases
#720ANIMAL-FREE DIETARY COLLAGEN
#721THERAPEUTIC MITOCHONDRIAL PEPTIDES
#722ADIPONECTIN PEPTIDOMIMETICS FOR TREATING OCULAR DISORDERS
#723METHODS OF B CELL EXPANSION FOR USE IN CELL THERAPY
#724PLURIPOTENT STEM CELL, NERVE CELL, AND APPLICATION THEREOF
#725NOVEL EUKARYOTIC CELLS AND METHODS FOR RECOMBINANTLY EXPRESSING A PRODUCT OF INTEREST
#726Polypeptide combination used for tumour immunotherapy, and preparation method therefor
#727WNT COMPOSITIONS AND METHODS FOR SERUM-FREE SYNTHESIS
#728Peptide analogs
#729MULTISPECIFIC TRANSTHYRETIN IMMUNOGLOBULIN FUSIONS
#730AAV VECTORS WITH MYELIN PROTEIN ZERO PROMOTER AND USES THEREOF FOR TREATING SCHWANN CELL-ASSOCIATED DISEASES LIKE CHARCOT-MARIE-TOOTH DISEASE
#731NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#732EX VIVO ANTIGEN-PRESENTING CELLS OR ACTIVATED CD-POSITIVE T CELLS FOR TREATMENT OF CANCER
#733Chimeric protein and related genic transfer technology
#734C-carbon linked glutarimide degronimers for target protein degradation
#735METHODS AND COMPOSITIONS FOR TREATING CANCER
#736COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF PRION DISEASE
#737Specific Nuclear-Anchored Independent Labeling System
#738GRP78-binding antibodies and uses thereof and selection of phage-displayed accessible recombinant targeted antibodies
#739BIFUNCTIONAL STAPLED POLYPEPTIDES AND USES THEREOF
#740ULTRASOUND-BASED THERMOGENETICS FOR IMMUNOTHERAPY
#741METHOD OF IDENTIFYING INTRACELLULAR SECRETORY PROTEIN OR TISSUE-SPECIFIC SECRETORY PROTEIN
#742ENGINEERED T CELLS AND USES THEREFOR
#743Highly Efficient DNA Base Editors Mediated By RNA-Aptamer Recruitment For Targeted Genome Modification And Uses Thereof
#744Recombinant fused polypeptide and use thereof
#745SCHIZOPHRENIA-RELATED MICRODELETION GENE 2510002D24Rik IS ESSENTIAL FOR SOCIAL MEMORY
#746EPITOPES
#747METHOD FOR THE DETECTION OF CANCER CELLS BY LOCALIZATION OF PEPTIDES IN NUCLEUS AS COMPARED TO CYTOPLASM
#748SINGLE CHAIN FUSIONCONSTRUCTS COMPRISING MULTIMERIC ANTIBODY FRAGMENTS FUSED TO COLLAGEN TRIMERIZATION DOMAINS
#749Efficient delivery of therapeutic molecules to cells of the inner ear
#750Methods and compositions for regenerating tissues
#751SATIATION PEPTIDES FOR WEIGHT LOSS AND ALTERED TASTE SENSITIVITY
#752Peptides and combination of peptides for use in immunotherapy against various cancers
#753Peptides and combination of peptides for use in immunotherapy against various cancers
#754TARGETING OF THE CYTOSKELETON AS A THERAPEUTIC APPROACH FOR NEURODEGENERATIVE DISEASE
#755FIBRONECTIN BINDING DOMAINS WITH REDUCED IMMUNOGENICITY
#756METHOD FOR THE PREPARATION OF LOW MOLECULAR WEIGHT PORCINE LYMPHO-RETICULAR POLYPEPTIDES AND FORMULATIONS THEREOF
#757CIRCULARLY PERMUTATED HALOALKANE TRANSFERASE FUSION MOLECULES
#758Adeno-associated viral chimeric TDP-43 proteins
#759NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS CANCERS
#760Compositions and Methods for Treating Elevated Secretory Activity
#761IMMUNE CELLS WITH ENHANCED CYTOTOXICITY AND METHODS OF USE THEREOF
#762NANOSPHERES OF SEC14-LIKE PROTEINS AND COGNATE LIGANDS
#763Engineered Fc constructs
#764CANCER VACCINES TARGETING LEMD1 AND USES THEREOF
#765Peptides and combination of peptides for use in immunotherapy against various cancers
#766Peptides and combination of peptides for use in immunotherapy against various cancers
#767Peptides and combination of peptides for use in immunotherapy against various cancers
#768POLYPEPTIDE-POLYMER CONJUGATES AND METHODS OF USE THEREOF
#769METHODS FOR THE DIAGNOSIS AND TREATMENT OF GASTROINTESTINAL STROMAL TUMORS
#770INCREASING ATOH1 LIFE TO DRIVE SENSORINEURAL HAIR CELL DIFFERENTIANTION
#771Methods and compositions related to recombinant NEIL2
#772COMPOSITIONS AND METHODS FOR TREATING PROTEIN AGGREGATION-ASSOCIATED DISEASES
#773Peptides and combination of peptides for use in immunotherapy against various cancers
#774Peptides and combination of peptides for use in immunotherapy against various cancers
#775COMPOSITION COMPRISING MLS-STAT3 FOR PREVENTION OR TREATMENT OF IMMUNE DISEASE
#776Peptides and combination of peptides for use in immunotherapy against various cancers
#777Engineered muscle targeting compositions
#778RECOMBINANT FAP BINDING PROTEINS AND THEIR USE
#779COLD-SHOCK PROTEIN SCAFFOLD FOR ENGINEERING NON-ANTIBODY BINDING PROTEINS
#780Therapeutic peptides
#781MODIFIED VIRAL PARTICLES AND USES THEREOF
#782METHODS FOR PREPARATION OF ACTIVE SEPARASE
#783NOVEL ANKYRIN REPEAT BINDING PROTEINS AND THEIR USES
#784SPECIFIC NUCLEAR-ANCHORED INDEPENDENT LABELING SYSTEM
#785Recombinant intravenous immunoglobulin (RIVIG) compositions and methods for their production and use
#786NOVEL ARTIFICIAL NUCLEIC ACID MOLECULES
#787METHOD OF DIAGNOSING CANCER AND DIAGNOSIS KIT USING MEASUREMENT OF NK CELL ACTIVITY
#788Polypeptide and related products, methods and uses
#789Methods for efficient delivery of therapeutic molecules in vitro and in vivo
#790NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST CLL AND OTHER CANCERS
#791Compositions and method of use for hair straightening and shaping
#792METHODS FOR DETECTING TRAUMATIC BRAIN INJURY
#793Compositions for treatment of vascular disease
#794INTERFERON REGULATORY FACTOR 5 INHIBITORS AND USES THEREOF
#795Compositions and methods relating to novel sulfono-gamma-AA peptides
#796BONE-SPECIFIC COMPLEX COMPRISING BONE CELL TRANSFORMATION RECOMBINANT PROTEIN AND BONE-TARGETING MOLECULE
#797Compositions for modulating an XBP1 pathway in a keratinocyte and methods of use
#798Rapid assay for detection of SARS-CoV-2 antibodies
#799Peptides and combination of peptides for use in immunotherapy against various tumors
#800TRIPLE GLUCAGON/GLP-1/GIP RECEPTOR AGONIST
#801Progranulin variants
#802WORMS Scaffolds: Multi-scale protein complexes
#803REGULATORY T CELL EPITOPES, COMPOSITIONS AND USES THEREOF
#804ENGINEERED ENDOTHELIAL CELLS EXPRESSING AN ETS TRANSCRIPTION FACTOR
#805CONDITIONED MEDIUM AND EXTRACELLULAR MATRIX COMPOSITIONS FROM CELLS CULTURED UNDER HYPOXIC CONDITIONS
#806ICAM-1 targeted fusion enzymes
#807TARGETING DEREGULATED WNT SIGNALING IN CANCER USING STABILIZED ALPHA-HELICES OF BCL-9
#808Peptide, compositions and method for delivery of agents into cells and tissues
#809GENE THERAPIES FOR USHER SYNDROME (USH2A)
#810ADENO-ASSOCIATED VIRUS DELIVERY OF CLN6 POLYNUCLEOTIDE
#811Polynucleotides encoding monoclonal antibodies binding to human pituitary adenylate cyclase-activating polypeptide type I receptor (PAC1) and methods of making thereof
#812MULTI-EPITOPIC CONSTRUCT
#813Neoantigen peptide mimics
#814SUMO PEPTIDES FOR TREATING NEURODEGENERATIVE DISEASES
#815PROTEINS WITH CARDIOPROTECTIVE ACTIVITY
#816RECOMBINANT AAV-CRUMBS HOMOLOGUE COMPOSITION AND METHODS FOR TREATING LCA-8 AND PROGRESSIVE RP
#817PHARMACEUTICAL COMPOSITION COMPRISING FRATAXIN FUSION PROTEIN AND METHODS OF USE THEREOF
#818TFEB MUTANTS AND THEIR USE IN THE TREATMENT AND/OR PREVENTION OF DISORDERS THAT REQUIRE THE INDUCTION OF THE CELLULAR AUTOPHAGY-LYSOSOMAL SYSTEM
#819AMANTADINE BINDING PROTEIN
#820Novel Complex Comprising A Cell Penetrating Peptide, A Cargo And A TLR Peptide Agonist For Treatment Of Glioblastoma
#821THERAPY FOR SUBARACHNOID HEMORRHAGE AND ISCHEMIA
#822METHOD FOR REDUCING THE IMMUNE RESPONSE TO A BIOLOGICALLY ACTIVE PROTEIN
#823NOVEL FUSION MOLECULES AND USES THEREOF
#824Variant of a BPIFB4 protein
#825METHODS AND COMPOSITIONS FOR REDUCING METASTASES
#826PUMILIO DOMAIN-BASED MODULAR PROTEIN ARCHITECTURE FOR RNA BINDING
#827Method of treating skin tissue damage by topically administering a bi-specific protein comprising a human insulin-like growth factor variant and a human annexin A5 variant
#828OPTOGENETIC MODULATION BY MULTI-CHARACTERISTIC OPSINS FOR VISION RESTORATION AND OTHER APPLICATIONS THEREOF
#829PRODUCTION AND USES OF ARTIFICAL HISTONE H1 FOR ANALYZING, DIAGNOSING, TREATING, AND/OR PREVENTING SENESCENCE
#830Chelating platform for delivery of radionuclides
#831NEOANTIGEN ENGINEERING USING SPLICE MODULATING COMPOUNDS
#832SYNTHETIC PEPTIDE, RELATIVE ARTIFICIAL ANTIGEN, RELATIVE ANTI-EHD2 ANTIBODY AND PREPARATION METHOD THEREOF AND USE THEREOF
#833Novel Fusion Proteins Specific for CD137 and GPC3
#834Integrin antagonists
#835Exosome-targeted DNA vaccine
#836High affinity anticalins directed against human CD98hc
#837NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS
#838Cancer Antigen Peptide
#839Cancer Antigen Peptide
#840Cancer Antigen Peptide
#841Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#842MODIFIED MITOCHONDRION AND METHODS OF USE THEREOF
#843Artificial nucleases comprising engineered cleavage half-domains
#844Proteins specific for CD137
#845VACCINE COMPOSITIONS COMPRISING AN AMPHIPATHIC COMPOUND, A NEOANTIGEN AND A HYDROPHOBIC CARRIER, AND METHODS OF USE THEREOF
#846Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#847NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST PROSTATE CANCER AND OTHER CANCERS
#848Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#849METHODS FOR ENHANCING LIFESPAN AND/OR TREATING CELLULAR PROLIFERATIVE DISORDERS BY TRANSPLANTATION
#850RECOMBINANT ADENO-ASSOCIATED VIRUS FOR TREATMENT OF GRN-ASSOCIATED ADULT-ONSET NEURODEGENERATION
#851TUNABLE ENDOGENOUS PROTEIN DEGRADATION
#852NOVEL USE OF REGULATORY T CELL-SPECIFIC SURFACE PROTEIN LRIG-1
#853Alpha-synuclein substrates and methods for making and using the same
#854SECRETORY PROTEIN
#855Smart single-domain intrabodies with precision switches for biomedical applications
#856Zinc Finger Protein-Superoxide Dismutase Fusion Protein With Cell Membrane Penetrating Property
#857Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#858Adeno-Associated Virus Delivery of CLN3 Polynucleotide
#859DELIVERY OF POLYNUCLEOTIDES USING RECOMBINANT AAV9
#860Peptides and combination of peptides for use in immunotherapy against prostate cancer and other cancers
#861PAR2 MODULATION AND METHODS THEREOF
#862TREATMENT OF DISEASES WITH MULTIMERIC PEPTIDES
#863Compositions for preventing or treating viral and other microbial infections
#864DUAL IL-2R AND IL-7R BINDING COMPOUNDS
#865Protein inhibitors with reduced immunogenicity and resistance to degradation, and methods for their preparation and use
#866Organic solvent method for preparing membrane protein based nanosheets and membranes based on nanosheets
#867TXNIP AND LDHB COMPOSITIONS AND METHODS FOR THE TREATMENT OF DEGENERATIVE OCULAR DISEASES
#868H3.3 CTL PEPTIDES AND USES THEREOF
#869Modulation of proprotein convertase subtilisin/kexin 9 expression (PCSK9) with HSP 27 and/or HSP25
#870ENGINEERED TUBEROUS SCLEROSIS COMPLEX 2 POLYPEPTIDES
#871CELLULAR VAMP CLEAVAGE ASSAY
#872Plakophillin-2 gene therapy methods and compositions
#873RECOMBINANT PEPTIDE-MHC COMPLEX BINDING PROTEINS AND THEIR GENERATION AND USE
#874Antibody composition specifically recognizing an immunogenic fragment peptide of EN2 protein
#875Antibody composition specifically recognizing an immunogenic fragment peptide of EN2 protein
#876Methods of treatment comprising Selenoprotein P fragment-containing compounds
#877ISL1 and LHX3 VECTOR
#878ISOLATED GDF TRAP POLYPEPTIDE
#879Engineered PD-1 variants
#880EXTRACELLULAR VESICLE COMPRISING A FUSION PROTEIN HAVING FC BINDING CAPACITY
#881Lipocalin muteins with binding affinity for LAG-3
#882INHIBITOR OF DUX4 AND USES THEREOF
#883PEPTIDE TAGS FOR LIGAND INDUCED DEGRADATION OF FUSION PROTEINS
#884COMPOSITIONS FOR THE TREATMENT OF DISEASE
#885NANOCARRIERS HAVING SURFACE CONJUGATED PEPTIDES AND USES THEREOF FOR SUSTAINED LOCAL RELEASE OF DRUGS
#886Compounds and Methods Useful for Detection and Treatment of Cancer
#887METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT AND THE PREVENTION OF CARDIOMYOPATHY DUE TO ENERGY FAILURE
#888METHODS AND COMPOSITIONS FOR ALTERING FUNCTION AND STRUCTURE OF CHROMATIN LOOPS AND/OR DOMAINS
#889Methods and systems for in-vitro milk production
#890Methods and systems for in-vitro milk production
#891Methods and systems for in-vitro milk production
#892Methods and systems for in-vitro milk production
#893Methods and systems for in-vitro milk production
#894Protein binding to fibronectin B domain
#895ANGIOGENIC CONDITIONING TO ENHANCE CARDIAC CELLULAR REPROGRAMMING OF FIBROBLASTS OF THE INFARCTED MYOCARDIUM
#896ARTIFICIAL RIBOSOMES FOR FULLY PROGRAMMABLE SYNTHESIS OF NONRIBOSOMAL PEPTIDES
#897WHEY PROTEIN MICELLES AGAINST MUSCLE ATROPHY AND SARCOPENIA
#898Polynucleotides encoding Citrin for the treatment of Citrullinemia type 2
#899TALEN-BASED AND CRISPR/CAS-BASED GENE EDITING FOR BRUTON'S TYROSINE KINASE
#900COMPOSITIONS AND METHODS FOR ENHANCING THE PLURIPOTENCY OF STEM CELLS